Protocol to investigate the effect of cyclo-oxyganase (COX)-2 inhibition on reducing central sensitisation of pain in osteoarthritis.

Trial Profile

Protocol to investigate the effect of cyclo-oxyganase (COX)-2 inhibition on reducing central sensitisation of pain in osteoarthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2013

At a glance

  • Drugs Etoricoxib (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jul 2011 Status changed from completed to recruiting as reported by European Clinical Trials Database record.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
    • 01 Mar 2009 Status changed from recruiting to completed as reported by ISRCTN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top